1. MARKETS
  2. SECTOR : PHARMA & BIOTECH
  3. INDUSTRY : BIOTECH
  4. EDITAS MEDICINE INC
Editas Medicine Inc XNAS: EDIT
2.56 -0.20 (-7.25%)
1.6M
XNAS Volume

XNAS 10 Sep, 2025 5:30 PM (EDT)

Editas Medicine Inc - EDIT - stock price prediction, stock price target, analyst ratings from 14 analysts

Editas Medicine Inc has a share price target of US$ 4, revenue growth forecast of -36.3%, and profit growth estimate of 24.3% for FY25, based on top 14 analyst calls.